With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline Pharmaceuticals

It is a mixed bag but API is definitely a very big element in the pharma industry which is emerging as one of the big component for growth for certain companies. There is also big support from the government for API.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sCywmU
via IFTTT